Figure 1 | Scientific Reports

Figure 1

From: ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression

Figure 1

Comparison of the expression of ANXA2 in gliomas of different WHO grades and IDH statuses. ANXA2 was significantly highly expressed in HGG and IDH-wildtype gliomas in the TCGA and CGGA datasets. The expression of ANXA2 in the TCGA dataset according to WHO grade (A) and IDH status (overall WHO grades (C), WHO II (E), WHO III (G), WHO IV (I)). The expression of ANXA2 in the CGGA dataset according to WHO grades (B) and IDH status (overall WHO grades (D), WHO II (F), WHO III (H), WHO IV (J)). *P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001.

Back to article page